QUEST DIAGNOSTICS INC is 4.7x more valuable than Caris Life Sciences, Inc. by market capitalization ($22.56 B vs $4.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DGX | CAI |
|---|---|---|
| Market cap | $22.56 B | $4.85 B |
| US-listed rank | #570 | #1404 |
| Revenue (latest FY) | $11.04B | $812.03M |
| Net income (latest FY) | $992.00M | -$68.09M |
| Net margin | 9.0% | -8.4% |
| P/E (trailing FY) | 22.7 | - |
| SEC filings | 2,372 | 102 |
QUEST DIAGNOSTICS INC is 4.7x more valuable than Caris Life Sciences, Inc. by market capitalization ($22.56 B vs $4.85 B).
In their latest fiscal years, QUEST DIAGNOSTICS INC reported $11.04B in revenue while Caris Life Sciences, Inc. reported $812.03M.
Full pages: QUEST DIAGNOSTICS INC and Caris Life Sciences, Inc., or browse the full rankings.